- Home
- PRPO vs XCUR Comparison
PRPO vs XCUR Comparison
Compare PRPO & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- XCUR
- Stock Information
- Founded
- PRPO N/A
- XCUR 2011
- Country
- PRPO United States
- XCUR United States
- Employees
- PRPO N/A
- XCUR N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- PRPO Industrials
- XCUR Health Care
- Exchange
- PRPO Nasdaq
- XCUR Nasdaq
- Market Cap
- PRPO 32.4M
- XCUR 29.4M
- IPO Year
- PRPO N/A
- XCUR N/A
- Fundamental
- Price
- PRPO $20.50
- XCUR $3.75
- Analyst Decision
- PRPO
- XCUR
- Analyst Count
- PRPO 0
- XCUR 0
- Target Price
- PRPO N/A
- XCUR N/A
- AVG Volume (30 Days)
- PRPO 11.3K
- XCUR 17.2K
- Earning Date
- PRPO 11-17-2025
- XCUR 11-07-2025
- Dividend Yield
- PRPO N/A
- XCUR N/A
- EPS Growth
- PRPO N/A
- XCUR N/A
- EPS
- PRPO N/A
- XCUR N/A
- Revenue
- PRPO $21,242,000.00
- XCUR N/A
- Revenue This Year
- PRPO N/A
- XCUR N/A
- Revenue Next Year
- PRPO N/A
- XCUR N/A
- P/E Ratio
- PRPO N/A
- XCUR N/A
- Revenue Growth
- PRPO 27.05
- XCUR N/A
- 52 Week Low
- PRPO $3.90
- XCUR $2.62
- 52 Week High
- PRPO $22.38
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- PRPO 51.49
- XCUR 36.89
- Support Level
- PRPO $19.00
- XCUR $3.59
- Resistance Level
- PRPO $21.00
- XCUR $4.25
- Average True Range (ATR)
- PRPO 1.05
- XCUR 0.26
- MACD
- PRPO -0.16
- XCUR -0.08
- Stochastic Oscillator
- PRPO 27.44
- XCUR 7.34
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.